NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC) stock: key figures, P/E, revenue and dividend

Health Care · United States · ISIN US64130M2098

Price
0.75 USD
Market cap
6.81 m USD
P/E (2026)
–
P/S (2026)
–
Dividend yield
0.00 %
Net margin
–
Return on equity (ROE)
–
Return on assets (ROA)
–

NEUROONE MEDICAL TECHNOLOGIES Corp financials

Fiscal year2025
Revenue9.10 m USD
Gross profit5.14 m USD
Operating income-4.23 m USD
EBIT-3.61 m USD
Net income-3.61 m USD
Diluted EPS – continuing operations-0.09 USD

Full history since 2009, charts and your own formulas

This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.

About NEUROONE MEDICAL TECHNOLOGIES Corp

NeuroOne Medical Technologies Corporation, a medical technology company, provides solutions for continuous electroencephalogram (cEEG) and stereoelectrocencephalography (sEEG) recording in the United States. The company also provides solutions for spinal cord stimulation, brain stimulation, drug delivery and ablation solutions for patients suffering from epilepsy, trigeminal neuralgia, Parkinson's disease, dystonia, essential tremors, and chronic pain due to failed back surgeries and other pain-related neurological disorders. The company has a collaboration with the Department of Neurology's Division of Epilepsy at the University of Minnesota Medical School to advance a study evaluating epilepsy therapies. The company is based in Eden Prairie, Minnesota.

More stocks

All stocks →

Not investment advice. All data without warranty, price as of 12.11.2026. Details in the risk notice.